Clinical Trial Update: Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial tested low-dose naproxen in cognitively intact individuals at risk for Alzheimer's dementia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Naproxen (Naproxen)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Alzheimer Disease, Cognitive Decline Due to Alzheimer Disease | Phase 2 | Status: COMPLETED